Extracellular Vesicles, Circadian Rhythms, and Cancer: A Comprehensive Review with Emphasis on Hepatocellular Carcinoma

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Jul 27

PMID 39061191

Authors

Baharan Fekry

Lierni Ugartemendia

Nestor F Esnaola

Laura Goetzl

Affiliations

Soon will be listed here.

Abstract

This review comprehensively explores the complex interplay between extracellular vesicles (ECVs)/exosomes and circadian rhythms, with a focus on the role of this interaction in hepatocellular carcinoma (HCC). Exosomes are nanovesicles derived from cells that facilitate intercellular communication by transporting bioactive molecules such as proteins, lipids, and RNA/DNA species. ECVs are implicated in a range of diseases, where they play crucial roles in signaling between cells and their surrounding environment. In the setting of cancer, ECVs are known to influence cancer initiation and progression. The scope of this review extends to all cancer types, synthesizing existing knowledge on the various roles of ECVs. A unique aspect of this review is the emphasis on the circadian-controlled release and composition of exosomes, highlighting their potential as biomarkers for early cancer detection and monitoring metastasis. We also discuss how circadian rhythms affect multiple cancer-related pathways, proposing that disruptions in the circadian clock can alter tumor development and treatment response. Additionally, this review delves into the influence of circadian clock components on ECV biogenesis and their impact on reshaping the tumor microenvironment, a key component driving HCC progression. Finally, we address the potential clinical applications of ECVs, particularly their use as diagnostic tools and drug delivery vehicles, while considering the challenges associated with clinical implementation.

References

Li X, Guan J, Jiang Z, Cheng S, Hou W, Yao J . Microglial Exosome miR-7239-3p Promotes Glioma Progression by Regulating Circadian Genes. Neurosci Bull. 2021; 37(4):497-510. PMC: 8055789. DOI: 10.1007/s12264-020-00626-z. View

Chen L, Chen R, Velazquez V, Brigstock D . Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p. Am J Pathol. 2016; 186(11):2921-2933. PMC: 5222964. DOI: 10.1016/j.ajpath.2016.07.011. View

Tao S, Guo S . Extracellular Vesicles: Potential Participants in Circadian Rhythm Synchronization. Int J Biol Sci. 2018; 14(12):1610-1620. PMC: 6216034. DOI: 10.7150/ijbs.26518. View

Arbelaiz A, Azkargorta M, Krawczyk M, Santos-Laso A, Lapitz A, Perugorria M . Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2017; 66(4):1125-1143. DOI: 10.1002/hep.29291. View

Cao L, Yang X, Chen Y, Zhang D, Jiang X, Xue P . Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth. Mol Cancer. 2019; 18(1):148. PMC: 6815431. DOI: 10.1186/s12943-019-1075-2. View

Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View

Almeria C, Kress S, Weber V, Egger D, Kasper C . Heterogeneity of mesenchymal stem cell-derived extracellular vesicles is highly impacted by the tissue/cell source and culture conditions. Cell Biosci. 2022; 12(1):51. PMC: 9063275. DOI: 10.1186/s13578-022-00786-7. View

Haraszti R, Didiot M, Sapp E, Leszyk J, Shaffer S, Rockwell H . High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016; 5:32570. PMC: 5116062. DOI: 10.3402/jev.v5.32570. View

Eguchi A, Yan R, Pan S, Wu R, Kim J, Chen Y . Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice. J Mol Med (Berl). 2020; 98(7):1021-1034. PMC: 7810220. DOI: 10.1007/s00109-020-01926-7. View

10.

Locker G, Hamilton S, Harris J, Jessup J, Kemeny N, Macdonald J . ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006; 24(33):5313-27. DOI: 10.1200/JCO.2006.08.2644. View

11.

Yang J, Dong W, Zhang H, Zhao H, Zeng Z, Zhang F . Exosomal microRNA panel as a diagnostic biomarker in patients with hepatocellular carcinoma. Front Cell Dev Biol. 2022; 10:927251. PMC: 9537616. DOI: 10.3389/fcell.2022.927251. View

12.

Dai W, Wang Y, Yang T, Wang J, Wu W, Gu J . Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals. Cell Commun Signal. 2019; 17(1):113. PMC: 6721425. DOI: 10.1186/s12964-019-0423-6. View

13.

Chen L, Guo P, He Y, Chen Z, Chen L, Luo Y . HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Cell Death Dis. 2018; 9(5):513. PMC: 5938707. DOI: 10.1038/s41419-018-0534-9. View

14.

Bebelman M, Smit M, Pegtel D, Baglio S . Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther. 2018; 188:1-11. DOI: 10.1016/j.pharmthera.2018.02.013. View

15.

Taghikhani A, Farzaneh F, Sharifzad F, Mardpour S, Ebrahimi M, Hassan Z . Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy. Front Immunol. 2020; 11:221. PMC: 7069476. DOI: 10.3389/fimmu.2020.00221. View

16.

Park N, Zhou H, Elashoff D, Henson B, Kastratovic D, Abemayor E . Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009; 15(17):5473-7. PMC: 2752355. DOI: 10.1158/1078-0432.CCR-09-0736. View

17.

Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F . SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell. 2008; 134(2):317-28. DOI: 10.1016/j.cell.2008.06.050. View

18.

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

19.

Fekry B, Ribas-Latre A, Van Drunen R, Santos R, Shivshankar S, Dai Y . Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis. FASEB J. 2022; 36(9):e22482. PMC: 10062014. DOI: 10.1096/fj.202101398R. View

20.

Lok A, Sterling R, Everhart J, Wright E, Hoefs J, Di Bisceglie A . Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology. 2009; 138(2):493-502. PMC: 2819612. DOI: 10.1053/j.gastro.2009.10.031. View